NGVT
NGVT
NYSE · Chemicals

Ingevity Corp

$63.62
-1.73 (-2.65%)
As of Mar 22, 10:00 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.39B
Net Income
-425,051,507
Gross Margin
32.3%
Profit Margin
-30.6%
Rev Growth
+0.4%
D/E Ratio
7.18
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 32.3% 32.3% 54.7% 54.7%
Operating Margin -38.1% -34.3% 9.7% 8.4%
Profit Margin -30.6% -29.1% 8.3% 7.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.39B 1.38B 1.58B 1.41B
Gross Profit 449.14M 447.53M 864.01M 770.79M
Operating Income -529,024,686 -474,414,325 152.89M 118.22M
Net Income -425,051,507 -381,174,129 130.65M 101.13M
Gross Margin 32.3% 32.3% 54.7% 54.7%
Operating Margin -38.1% -34.3% 9.7% 8.4%
Profit Margin -30.6% -29.1% 8.3% 7.2%
Rev Growth +0.4% +0.4% +17.8% +22.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.14B 1.14B 220.13M 210.25M
Total Equity 159.47M 159.47M 1.03B 929.02M
D/E Ratio 7.18 7.18 0.21 0.23
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -402,626,555 -381,123,183 192.21M 179.91M
Free Cash Flow 123.30M 118.87M